Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 15 Jul 2024
Will promising response rates translate into a survival benefit?
Read Full News8 Pulmonology Headlines You Missed in September 2026
The Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 extends federal support for ALS research and expanded access to investigational therapies, with additional provisions addressing clinical trial oversight and regulatory planning.
The professor of neurology at the University of Lyon and 2026 Rachel Horne Prize Winner discussed pregnancy counseling, therapeutic inertia, and overlooked women's health issues in multiple sclerosis.
Jennifer Soung, MD, and Mona Shahriari, MD, discuss diagnosing psoriasis in diverse skin tones and why severity scores overlook dyspigmentation.
AMETHYST: Litifilimab Sustains CLE Gains at 52 Weeks, With Victoria Werth, MD
EADV Congress 2026: Day 3 Recap—5 Headlines to Know
Upadacitinib Tops Nemolizumab on Skin, Itch Targets in Indirect Analysis
1.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
2.
EBCC: European Breast Cancer Conference
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Fitness levels for the heart and lungs are linked to a lower mortality from cancer in men.
5.
Long-Acting Interferon Therapy Approved for ET
1.
The Pros and Cons of Using Cyclophosphamide in Cancer Treatment
2.
New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results
3.
Clinical Guidance for Survivorship-Focused Cancer Care
4.
Asymptomatic Thrombocytopenia: Unraveling the Enigma of Low Platelet Counts Without Symptoms
5.
Cancer Vaccines in Solid Tumors: Current Landscape, Mechanisms, and Clinical Implications
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
How Multidisciplinary Teams Support Modern Cancer Care
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge